Data protection Impressum

Healthcare

ATANIS Biotech, a leader in allergy diagnostics, has raised capital to advance its novel allergy test, FAST-PASE.

ATANIS Biotech secures new funding to launch its FAST-PASE allergy diagnostic test

28 October 2024

Three Geneva-based start-ups - Dyneo Technologies, Adoram Therapeutics and ex vivo - have received CHF 250,000 from the FONGIT Innovation Fund to advance solutions in cleantech, life sciences and virtual reality.

Three innovative Geneva-based start-ups receive FIF funding

28 October 2024

Nestled in the quiet industrial zone of Domdidier, in the canton of Fribourg, Medistri has grown into a key player in the highly specialized field of sterilization for medical and pharmaceutical industries.

Medistri, Fribourg’s hidden champion in medtech and pharmaceutical sterilization

22 October 2024

Switzerland has long been known as a global hub for cutting-edge innovation, and the recent visit of the Club de Paris des Directeurs de l'Innovation provided a unique opportunity to showcase the vibrant ecosystem in Western Switzerland. Co-organized by Greater Geneva Bern area (GGBa), this three-day learning journey brought together leaders and innovators from various sectors, eager to explore and exchange ideas on technological advancement and collaboration.

Discovering Swiss Innovation with the Club de Paris des Directeurs de l’Innovation

21 October 2024

Researchers at the University of Bern and the Bern University Hospital have developed a new test that simplifies and improves the accuracy of allergy diagnosis.

Allergy test developed by Bern researchers shows higher accuracy in diagnosing food allergies

15 October 2024

Lymphatica Medtech, a Lausanne-based clinical-stage company specializing in innovative treatments for lymphedema, has raised EUR 17.9 million in a Series B funding round.

Lymphatica Medtech secures EUR 17.9 million to advance lymphedema treatment

15 October 2024

The canton of Fribourg, together with the Banque Cantonale de Fribourg (BCF), has revealed the nine finalists of the prestigious IFF (Innovation Fribourg Freiburg) Awards.

Fribourg unveils nine finalists for the 2024-2025 IFF Innovation Awards

15 October 2024

machineMD has received EU-MDR Class IIa certification for its neos™ neuro-ophthalmic diagnostic device, setting a new standard for eye movement and pupil function assessment in neurology and ophthalmology.

machineMD’s neos receives EU-MDR Class IIa Certification to advance neuro-ophthalmic diagnostics

14 October 2024

Atinary Technologies and Snapdragon Chemistry, a Cambrex company, have announced a strategic collaboration to integrate AI-driven process optimization technology with advanced pharmaceutical development capabilities, aiming to revolutionize drug development.

Atinary Technologies and Snapdragon Chemistry partner to optimize drug development with AI

9 October 2024

Phoenix Pharma Switzerland has announced the relocation of its Swiss headquarters to the Businesspark Liebefeld in Köniz, bringing 100 new jobs to the canton of Bern.

Phoenix Pharma Switzerland relocates its headquarters to the canton of Bern

2 October 2024

1 … 6 7 8 9 10 11 12 13 14 … 20